ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Lipid variability and risk of microvascular complications in Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: A post hoc analysis

Hukportie, Daniel Nyarko; Li, Fu-Rong*; Zhou, Rui; Zheng, Jia-Zhen; Wu, Xiao-Xiang; Zou, Meng-Chen*; Wu, Xian-Bo*广州军区广州总医院; 南方医科大学
Journal of Diabetes2022-6DOI: 10.1111/1753-0407.13273
2被引14阅读
引用收藏
分享

摘要

Background Greater lipid variability may cause adverse health events among diabetic patients. We aimed to examine the effect of lipid variability on the risk of diabetic microvascular outcomes among type 2 diabetes mellitus patients. Methods We assessed the association between visit-to-visit variability (measured by variability independent of mean) in high-density lipoprotein (HDL) cholesterol, low-density lipoprotein-cholesterol (LDL), triglyceride, and remnant cholesterol (RC) measurements among participants involved in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study and the risk of incident microvascular outcomes, including nephropathy, neuropathy, and retinopathy. Cox proportional hazards models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs), adjusted for potential confounders. Results There were 2400, 2470, and 2468 cases of nephropathy, neuropathy, and retinopathy during a follow-up period of 22 600, 21 542, and 26 701 person-years, respectively. Higher levels of HDL, triglyceride, and RC variability were associated with an increased risk of incident nephropathy and neuropathy. Compared with the lowest quartile, the fully adjusted HRs (95% CI) for the highest quartile of HDL, triglyceride, and RC variability for nephropathy risk were 1.57 (1.22, 2.01), 1.50 (1.18, 1.92), and 1.40 (1.09, 1.80), respectively; and for neuropathy, the corresponding risks were 1.36 (1.05, 1.75), 1.47 (1.14, 1.91), and 1.35 (1.04, 1.74), respectively. Null association was observed between LDL variability and all microvascular complications. Additionally, all associations of variability in the other lipids with retinopathy risk were null. Conclusion Among individuals with type 2 diabetes mellitus, HDL, triglyceride, and RC variability were associated with increased risks of nephropathy and neuropathy but not retinopathy. Trial registration: ClinicalTrials.gov., no. NCT00000620.

学科与关键词

关键词
high-density lipoproteinlow-density lipoproteinmicrovascular complicationsremnant cholesteroltriglyceride
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Journal of Diabetes
发表日期
2022-06
卷期
第 14 卷, 第 6 期
页码
365-376
DOI
10.1111/1753-0407.13273
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Guangdong Basic and Applied Basic Research Foundation [2021A1515011684]; Guangzhou Science and Technology Project [202102080597]; National Natural Science Foundation of China [82173607]; Open Project of the Guangdong Provincial Key Laboratory of Tropical Disease Research [2020B1212060042]; Novo Nordisk; King Pharmaceuticals; Centers for Disease Control and Prevention; National Eye Institute; National Institute on Aging; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; National Heart, Lung, and Blood Institute; Bayer HealthCare; Abbott Laboratories

作者

  • H

    Hukportie, Daniel Nyarko (第一作者)

    southern med univ

  • L

    Li, Fu-Rong (通讯)

    southern med univ

查看全部 7 位作者收起作者
  • Z

    Zhou, Rui

    southern med univ

  • Z

    Zheng, Jia-Zhen

    southern med univ

  • W

    Wu, Xiao-Xiang

    gen hosp guangzhou mil command

  • Z

    Zou, Meng-Chen (通讯)

    southern med univ

  • W

    Wu, Xian-Bo (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417